UPCARE - Trademark Details
Status: 686 - Published For Opposition
Serial Number
79298532
Word Mark
UPCARE
Status
686 - Published For Opposition
Status Date
2021-12-07
Filing Date
2020-10-21
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
261126 - Oblongs as carriers for words, letters or designs.
Published for Opposition Date
2021-12-07
Attorney Name
Law Office Assigned Location Code
N80
Employee Name
RIBAUDO, MICHELLE RACH
Statements
Indication of Colors claimed
The color(s) black, red, blue, green and orange is/are claimed as a feature of the mark.
Description of Mark
The mark consists of the wording "UPCARE" in black stylized font placed below two interlocking diagonal oblong shapes, with the top left shape being in red, the top right shape in green, the bottom left shape in orange and the bottom right shape in blue. The color white represents background, outlining, shading and/or transparent areas and is/are not part of the mark.
Goods and Services
Acne treatment preparations in the form of cleansers; anti-bacterial pharmaceutical preparations; Capsules sold empty for pharmaceutical purposes; effervescent analgesic pharmaceutical preparations; Extracts of plants in capsule form for pharmaceutical purposes; Throat lozenges for pharmaceutical purposes; pharmaceutical compound eye-drops; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations containing vitamins for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for animals for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for health care for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for human use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for nasal use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for oral use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for personal use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of acne; Pharmaceutical preparations for veterinary use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations in the form of emulsions for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations in the form of throat lozenges; Pharmaceutical preparations in the form of tablets for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical products for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical products derived from natural sources for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical products for use by humans for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical products in gel form for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical tablets for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; plant extracts for pharmaceutical use; Drug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations; medicated mouth spray; mouth sprays for medical use; medicated throat sprays; medicated mouthwashes; medical mouthwashes; mouthwashes and gargles for medical purposes; dietary supplements; dietary supplements for animals; herbal dietary supplements; vitamin supplements; vitamin supplements for animals; Nutritionally fortified herbal beverages for medicinal use; medical toothpastes; medicated toothpaste; eye drops; dietary supplements with a cosmetic effect
Pseudo Mark
UP CARE
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-12-02
Primary Code
005
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (Proprietary Limited Company).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (Proprietary Limited Company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (Proprietary Limited Company).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Katherine P. Califa
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1561693
International Registration Date
2020-10-21
International Publication Date
2020-11-26
International Renewal Date
2030-10-21
Auto Protection Date
2022-05-26
International Status
001 - Request for extension of protection established
International Status Date
2020-11-26
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event Date | Event Description |
2020-11-26 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2020-12-02 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-12-08 | APPLICATION FILING RECEIPT MAILED |
2021-03-22 | ASSIGNED TO EXAMINER |
2021-03-28 | NON-FINAL ACTION WRITTEN |
2021-03-29 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2021-04-05 | REFUSAL PROCESSED BY MPU |
2021-04-05 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2021-04-25 | REFUSAL PROCESSED BY IB |
2021-10-05 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-10-05 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-10-05 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-11-01 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2021-11-17 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2021-11-17 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
2021-11-17 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2021-12-06 | NOTIFICATION PROCESSED BY IB |
2021-12-07 | PUBLISHED FOR OPPOSITION |
2021-12-07 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |